you are here: HomeNewsIndia

Tamil Nadu records 1,019 new COVID-19 cases, 11 fatalities

A total of 64,441 samples were tested on Saturday, taking the cumulative total to 1,38,60,244 specimens examined so far.

December 26, 2020 / 11:01 PM IST
Representational image

Representational image

Tamil Nadu reported 1,019 new COVID-19 cases on Saturday, taking the infection count to 8,13,161, while 11 more fatalities pushed the death toll to 12,059.

Recoveries continued to outnumber the new infections with 1,098 people getting cured, taking the aggregate to 7,92,063, a health department bulletin said.

The number of active cases stood at 9,039. A total of 64,441 samples were tested on Saturday, taking the cumulative total to 1,38,60,244 specimens examined so far. According to the bulletin, five more returnees from the United Kingdom tested positive for the virus, taking the total number of such cases to 10.

Four were from Chennai, three from Thanjavur and one each from Nilgiris, Theni and Madurai,it said, adding all the UK returnee patients have been kept in separate isolation wards.

The State capital logged 295 new coronavirus cases, while the rest were scattered across other districts.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Chennai continued to top the list of cases with 2,24,094 infections of more than 8.13 lakh infections reported in the state.It also topped in the number of fatalities, accounting for 3,988 of the total 12,059 fatalities.

Fourteen districts added new cases in single digits, while 34 districts reported zero fatalities.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Dec 26, 2020 11:00 pm

stay updated

Get Daily News on your Browser
Sections